Bmi 1 is required for the initiation of pancreatic cancer through an Ink 4 a-independent mechanism
暂无分享,去创建一个
S. Morrison | K. Olive | L. Almada | D. Simeone | M. Collins | Luciana L Almada | Zhang | Shyam | Yan | Luciana L. Almada | Jaime A. Eberle | Heather K. Schofield | Nakada | Bednár | M. Fernandez-Zapico | Bardeesy | Pasca di Magliano
[1] M. Fernández-Zapico,et al. The Transcription Factor GLI1 Modulates the Inflammatory Response during Pancreatic Tissue Remodeling* , 2014, The Journal of Biological Chemistry.
[2] S. Morrison,et al. Prospective identification of functionally distinct stem cells and neurosphere-initiating cells in adult mouse forebrain , 2014, eLife.
[3] A. Krešo,et al. Self-renewal as a therapeutic target in human colorectal cancer , 2013, Nature Medicine.
[4] D. Simeone,et al. Bmi1 Enhances Tumorigenicity and Cancer Stem Cell Function in Pancreatic Adenocarcinoma , 2013, PloS one.
[5] M. Hebrok,et al. Bmi1 is required for regeneration of the exocrine pancreas in mice. , 2012, Gastroenterology.
[6] D. Reinberg,et al. EZH2 couples pancreatic regeneration to neoplastic progression. , 2012, Genes & development.
[7] C. Galbán,et al. Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. , 2012, The Journal of clinical investigation.
[8] Jason R. Gunn,et al. Acute Pancreatitis Accelerates Initiation and Progression to Pancreatic Cancer in Mice Expressing Oncogenic Kras in the Nestin Cell Lineage , 2011, PloS one.
[9] Scott E. Kern,et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis , 2011, Nature.
[10] M. Barbacid,et al. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. , 2011, Cancer cell.
[11] M. Esteller,et al. Aberrant epigenetic landscape in cancer: how cellular identity goes awry. , 2010, Developmental cell.
[12] D. Bar-Sagi,et al. Oncogenic KRas suppresses inflammation-associated senescence of pancreatic ductal cells. , 2010, Cancer cell.
[13] Jun Li,et al. Bmi‐1 is related to proliferation, survival and poor prognosis in pancreatic cancer , 2010, Cancer science.
[14] M. Hebrok,et al. Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice. , 2010, The Journal of clinical investigation.
[15] F. Real,et al. The epigenetic regulators Bmi1 and Ring1B are differentially regulated in pancreatitis and pancreatic ductal adenocarcinoma , 2009, The Journal of pathology.
[16] In Hye Lee,et al. Bmi1 regulates mitochondrial function and the DNA damage response pathway , 2009, Nature.
[17] M. Capecchi,et al. Bmi1 lineage tracing identifies a self-renewing pancreatic acinar cell subpopulation capable of maintaining pancreatic organ homeostasis , 2009, Proceedings of the National Academy of Sciences.
[18] A. Bhushan,et al. Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation. , 2009, Genes & development.
[19] G. Parmigiani,et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.
[20] J. Lees,et al. Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion , 2008, Proceedings of the National Academy of Sciences.
[21] M. Capecchi,et al. Bmi1 is expressed in vivo in intestinal stem cells , 2008, Nature Genetics.
[22] O. van Tellingen,et al. Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. , 2007, Cancer cell.
[23] M. Barbacid,et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. , 2007, Cancer cell.
[24] Daniel Chourrout,et al. Genome Regulation by Polycomb and Trithorax Proteins , 2007, Cell.
[25] T. Kawabe,et al. Dysregulated Expression of Stem Cell Factor Bmi1 in Precancerous Lesions of the Gastrointestinal Tract , 2006, Clinical Cancer Research.
[26] Anke Sparmann,et al. Polycomb silencers control cell fate, development and cancer , 2006, Nature Reviews Cancer.
[27] Ralph Weissleder,et al. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[28] Y. Arsenijévic,et al. Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice. , 2005, Genes & development.
[29] S. Morrison,et al. Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. , 2005, Genes & development.
[30] R. Hruban,et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.
[31] R. DePinho,et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. , 2003, Genes & development.
[32] E. Petricoin,et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. , 2003, Cancer cell.
[33] Hengbin Wang,et al. Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing , 2002, Science.
[34] R. DePinho,et al. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus , 1999, Nature.
[35] M. Sofroniew,et al. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. , 1994, Genes & development.
[36] Anton Berns,et al. Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging , 1991, Cell.
[37] R. Hruban,et al. Pancreatic cancer in mice and man: the Penn Workshop 2004. , 2006, Cancer research.
[38] Philippe Soriano. Generalized lacZ expression with the ROSA26 Cre reporter strain , 1999, Nature Genetics.